Company Overview
Snapshot
Founded in June 2015 by Ziv Ofek, Boaz Gur-Lavie, and Luz Erez, MDClone operates with 51–200 employees. The company has raised $104.25 million across 4 funding rounds from 5 investors. In March 2022, MDClone completed a Series C financing round, with new investors Warburg Pincus.
Business overview
MDClone provides a self-service data analytics environment designed for healthcare ecosystems. Its core offering, the MDClone ADAMS Platform, enables dynamic data exploration by utilizing synthetic data, continuous data feeds, and longitudinal data. The platform organizes, accesses, and protects patient data privacy, accelerating research, improving operations, and driving innovation. MDClone serves major health systems, payers, and life sciences customers across the United States, Canada, and Israel.
Strategic signal
In February 2023, MDClone launched the first ADAMS Center at Sheba Medical Center in Israel, a model designed to improve quality and performance through data leverage. This initiative demonstrates the company's ability to drive clinical and operational transformation by empowering healthcare teams with data, signaling strong growth potential and strategic validation of its platform's impact on patient care and cost management.
Log in to access full profile ›Company Intelligence Q&A
- What was a significant recent partnership for MDClone?
- In February 2023, MDClone partnered with Sheba Medical Center to inaugurate the world's first ADAMS Center, a hub for data-driven activities aimed at enhancing care delivery and operational efficiency.
- Which investors participated in MDClone's Series C funding round?
- In March 2022, MDClone completed a Series C financing round with participation from new investors Warburg Pincus.
- What recognition did MDClone receive in May 2022?
- In May 2022, MDClone was recognized as the Best Healthcare Big Data Platform for the second consecutive year in the MedTech Breakthrough Awards program, highlighting the impact of its ADAMS Platform.
- What was the outcome of MDClone's partnership with Intermountain Healthcare?
- In May 2021, Intermountain Healthcare's partnership with MDClone resulted in significant improvements for patients with chronic kidney disease, decreasing admissions by approximately 90% and generating $30 million in savings over 18 months.
- When did MDClone expand its operations into Canada?
- In February 2020, MDClone expanded its operations into Canada through a partnership with The Ottawa Hospital, introducing its platform to provide practitioners and researchers with synthetic patient data while ensuring privacy.